Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option

Immune checkpoints are promising targets in cancer therapy. Recently, poliovirus receptor (PVR) and poliovirus receptor-related 2 (PVRL2) have been identified as novel immune checkpoints. In this investigation we show that acute myeloid leukemia (AML) cell lines and AML patient samples highly expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Stamm, Hauke, Klingler, Felix, Grossjohann, Eva-Maria, Muschhammer, Jana, Vettorazzi, Eik, Heuser, Michael, Mock, Ulrike, Thol, Felicitas, Vohwinkel, Gabi, Latuske, Emily, Bokemeyer, Carsten, Kischel, Roman, Dos Santos, Cedric, Stienen, Sabine, Friedrich, Matthias, Lutteropp, Michael, Nagorsen, Dirk, Wellbrock, Jasmin, Fiedler, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160395/
https://www.ncbi.nlm.nih.gov/pubmed/29855615
http://dx.doi.org/10.1038/s41388-018-0288-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160395/
https://www.ncbi.nlm.nih.gov/pubmed/29855615
http://dx.doi.org/10.1038/s41388-018-0288-y

Ejemplares similares